Zoldria, Zoldria (zoledronic acid) 4 mg i.v. injection
Interchangeable drugs with the same active ingredient:
Aklasta
Blaster
Destron
Zolacid
Zoldria
Zoledo
Zoledronate-Richter
Zoledronate-Teva
Zoledronic Acid-Health
Zoledronic Acid
Zoledronic Acid Sandoz
Zoledronic Acid-Vista
Zoledronic Acid-Teva
Zoledronic Acid-Pharmex
Zolendran
Zoleum
Zoltero
Zoltonar
Zometa
Metakos
Monteron
Newzolen
Rezorb
zoldronate
Indications
Adjuvant therapy for hormone-dependent receptor-positive breast cancer in premenopausal women, together with hormonal therapy, which includes the use of gonadotropic releasing hormone (GnRH) agonists.
Prevention of symptoms associated with bone tissue damage (pathological fractures, compression of the vertebral trunk, complications after surgical interventions and radiation therapy, or hypercalcemia due to a malignant tumor) in patients with malignant neoplasms in the late stages.
Prevention of bone loss and bone fractures in women at an early stage
Postmenopausal breast cancer treated with aromatase inhibitors (AIs).
Treatment of hypercalcemia caused by a malignant tumor.
-
Commercial name:Золенат
-
Сhemical name:Zoledronic acid
-
Dosage:4 mg
-
Release form:Ampoule
-
Виробник:Индия